THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

HIGHBRIDGE CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000919185)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 166,234 Value ($000) $1,868 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 227,300 Value ($000) $1,962 Avg Close $9.65 Range $8.25 - $10.59
Q1 2023
Shares 230,100 Value ($000) $2 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 186,300 Value ($000) $2 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 225,000 Value ($000) $2,282 Avg Close $9.37 Range $7.53 - $11.00
Q2 2021
Shares 587,666 Value ($000) $8,533 Avg Close $18.78 Range $14.46 - $22.74
Q4 2015
Shares 17,976 Value ($000) $295 Avg Close $15.87 Range $10.56 - $19.75
Q1 2015
Shares 23,568 Value ($000) $409 Avg Close $18.33 Range $14.59 - $22.00
Q4 2014
Shares 57,773 Value ($000) $862 Avg Close $17.42 Range $13.11 - $24.06